ENDOTAG

MediGene AG

Application Filed: 2005-05-27
Trademark Application Details
Trademark Logo ENDOTAG

Mark For: ENDOTAG™ trademark registration is intended to cover the categories of medicines for humans and animals in the form of serums and diagnostic preparations for medical purposes and therapeutic use, namely, medicines for treating tumorous diseases such as gliomas, carcinomas of the colon, ovarian carcinomas, cervical carcinomas, carcinomas of the prostate, melanomas, basal cell carcinomas, actinic keratosis, breast cancers, bone cancers, brain cancers, colon cancers, endocrine system cancers, gastrointestinal cancers, gynaecological cancers, head and neck cancers, leukemias, lung cancers, lymphomas, metastases, myelomas, pediatric cancers, penile cancers, sarcomas, skin cancers, testicular cancers, thyroid cancers, urinary tract cancers, pleural cancers, neuronal cancers, mesotheliomas, astrocytomas, oligodendrogliomas, meningiomas, neurofibromas, glioblastomas, ependymomas, schwannomas, neurofibrosarcomas, neuroblastomas, pituitary gland cancers, cancers of the hypophysis, medulloblastomas, renal cell carcinomas, pancreatic cancers, gastric cancers, bladder cancers, liver cancers, prostate cancer, fibrosarcomas, squamous cell carcinomas, neuroectodermal cancers, hodgkin's lymphomas, non-hodgkin's lymphomas, hepatomas, epidermal carcinomas, or medicines for treating chronic inflammatory diseases such as rheumatoid arthritis, autoimmune diseases, allergies, multiple sclerosis; medicines for stimulating wound healing; medicines for treating eye diseases and arteriosclerosis; medicines for treating cardiovascular illnesses, namely, hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for treating skin diseases, namely, warts, genital warts and herpes; excluding medicines for enemas and for the preparation of a coloscopy. [all]

Status

2022-04-20 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Research OneLook Acronym Finder
Serial Number76677125
Mark Literal ElementsENDOTAG
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2008-10-30
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseYes
Current UseNo
Intent To UseYes
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameAdrienne L. White
Law Office AssignedM50
Employee NameVERHOSEK, WILLIAM T

Timeline

2005-05-27Application Filed
2008-03-18Published
2008-03-18Published for Opposition
2008-10-30Location: INTENT TO USE SECTION
2011-01-10Abandon
2011-01-10Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume
2011-01-10Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: MediGene AG
AddressLochhamer Strasse 11 82152 Planegg/Martinsried FED REP GERMANY
Legal Entity TypeAktiengesellschaft
Legal Entity StateFED REP GERMANY

Attorney of Record

Adrienne L. White
WRB-IP LLP
P.O. Box 476
Wadsworth OH 44282

Good, Services, and Codes

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Medicines for humans and animals in the form of serums and diagnostic preparations for medical purposes and therapeutic use, namely, medicines for treating tumorous diseases such as gliomas, carcinomas of the colon, ovarian carcinomas, cervical carcinomas, carcinomas of the prostate, melanomas, basal cell carcinomas, actinic keratosis, breast cancers, bone cancers, brain cancers, colon cancers, endocrine system cancers, gastrointestinal cancers, gynaecological cancers, head and neck cancers, leukemias, lung cancers, lymphomas, metastases, myelomas, pediatric cancers, penile cancers, sarcomas, skin cancers, testicular cancers, thyroid cancers, urinary tract cancers, pleural cancers, neuronal cancers, mesotheliomas, astrocytomas, oligodendrogliomas, meningiomas, neurofibromas, glioblastomas, ependymomas, schwannomas, neurofibrosarcomas, neuroblastomas, pituitary gland cancers, cancers of the hypophysis, medulloblastomas, renal cell carcinomas, pancreatic cancers, gastric cancers, bladder cancers, liver cancers, prostate cancer, fibrosarcomas, squamous cell carcinomas, neuroectodermal cancers, hodgkin's lymphomas, non-hodgkin's lymphomas, hepatomas, epidermal carcinomas, or medicines for treating chronic inflammatory diseases such as rheumatoid arthritis, autoimmune diseases, allergies, multiple sclerosis; medicines for stimulating wound healing; medicines for treating eye diseases and arteriosclerosis; medicines for treating cardiovascular illnesses, namely, hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for treating skin diseases, namely, warts, genital warts and herpes; excluding medicines for enemas and for the preparation of a coloscopy

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Medicines for humans and animals in the form of serums and diagnostic preparations for medical purposes and therapeutic use, namely, medicines for treating tumorous diseases such as gliomas, carcinomas of the colon, ovarian carcinomas, cervical carcinomas, carcinomas of the prostate, melanomas, basal cell carcinomas, actinic keratosis, breast cancers, bone cancers, brain cancers, colon cancers, endocrine system cancers, gastrointestinal cancers, gynaecological cancers, head and neck cancers, leukemias, lung cancers, lymphomas, metastases, myelomas, pediatric cancers, penile cancers, sarcomas, skin cancers, testicular cancers, thyroid cancers, urinary tract cancers, pleural cancers, neuronal cancers, mesotheliomas, astrocytomas, oligodendrogliomas, meningiomas, neurofibromas, glioblastomas, ependymomas, schwannomas, neurofibrosarcomas, neuroblastomas, pituitary gland cancers, cancers of the hypophysis, medulloblastomas, renal cell carcinomas, pancreatic cancers, gastric cancers, bladder cancers, liver cancers, prostate cancer, fibrosarcomas, squamous cell carcinomas, neuroectodermal cancers, hodgkin's lymphomas, non-hodgkin's lymphomas, hepatomas, epidermal carcinomas, or medicines for treating chronic inflammatory diseases such as rheumatoid arthritis, autoimmune diseases, allergies, multiple sclerosis; medicines for stimulating wound healing; medicines for treating eye diseases and arteriosclerosis; medicines for treating cardiovascular illnesses, namely, hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for treating skin diseases, namely, warts, genital warts and herpes; excluding medicines for enemas and for the preparation of a coloscopy

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED2011-01-10
ABANDONMENT - NO USE STATEMENT FILED2011-01-1099999
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2010-06-08
SOU EXTENSION 4 GRANTED2010-06-0769302
TEAS EXTENSION RECEIVED2010-06-02
SOU EXTENSION 4 FILED2010-06-0269302
SOU EXTENSION 3 GRANTED2009-12-0769302
TEAS EXTENSION RECEIVED2009-12-02
SOU EXTENSION 3 FILED2009-12-0269302
TEAS CHANGE OF CORRESPONDENCE RECEIVED2009-09-29
SOU EXTENSION 2 GRANTED2009-05-1469302
TEAS EXTENSION RECEIVED2009-05-12
SOU EXTENSION 2 FILED2009-05-0569302
SOU EXTENSION 1 GRANTED2008-10-3069302
CASE ASSIGNED TO INTENT TO USE PARALEGAL2008-10-2969302
TEAS EXTENSION RECEIVED2008-10-28
SOU EXTENSION 1 FILED2008-10-2869302
NOA MAILED - SOU REQUIRED FROM APPLICANT2008-06-10
PUBLISHED FOR OPPOSITION2008-03-18
NOTICE OF PUBLICATION2008-02-27
LAW OFFICE PUBLICATION REVIEW COMPLETED2008-02-1376243
EXAMINERS AMENDMENT MAILED2008-01-28
EXAMINERS AMENDMENT -WRITTEN2008-01-2677304
EXAMINER'S AMENDMENT ENTERED2008-01-2688888
APPROVED FOR PUB - PRINCIPAL REGISTER2008-01-26
TEAS/EMAIL CORRESPONDENCE ENTERED2008-01-1776243
CORRESPONDENCE RECEIVED IN LAW OFFICE2008-01-1776243
ASSIGNED TO LIE2008-01-1776243
TEAS RESPONSE TO OFFICE ACTION RECEIVED2007-12-06
NON-FINAL ACTION MAILED2007-06-06
NON-FINAL ACTION WRITTEN2007-06-0577304
APPLICATION FILING RECEIPT MAILED2007-06-05
ASSIGNED TO EXAMINER2007-06-0177304
NEW APPLICATION ENTERED IN TRAM2007-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed